US Government Spending on New Drugs With Incomplete and Postponed Mandatory Pediatric Trials

This cohort study estimates Medicare Part D, Medicaid, and Medicare Part B spending on pediatric drugs approved by the US Food and Drug Administration from 2015 to 2021.

Corresponding Author: Ian T. T. Liu, MD, JD, MPH, MS, Department of Pediatrics, University of Illinois Chicago, 1801 W Taylor St, Ste 2E, Chicago, IL 60612 (ian.liu@cuanschutz.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.